Showing results (801-810 of 1,286) with videos related to
Sort By:
Pageof 129
Journal of Cardiovascular Pharmacology and Therapeutics|August 9, 2011
Perconditioning and postconditioning: current knowledge, knowledge gaps, barriers to adoption, and future directionsJakob Vinten-Johansen, Weiwei ShiJournal of Cardiovascular Pharmacology and Therapeutics|August 9, 2011
The role of comorbidities in cardioprotectionMichael N Sack, Elizabeth MurphyJournal of Cardiovascular Pharmacology and Therapeutics|August 9, 2011
Remote ischemic conditioning: a clinical trial's updateLuciano Candilio, Derek J Hausenloy, Derek M YellonJournal of Cardiovascular Pharmacology and Therapeutics|August 9, 2011
Tc-99m SPECT sestamibi for the measurement of infarct sizeRaymond J GibbonsJournal of Cardiovascular Pharmacology and Therapeutics|August 9, 2011
Development of an NIH consortium for preclinicAl AssESsment of CARdioprotective therapies (CAESAR): a paradigm shift in studies of infarct size limitationDavid J Lefer, Roberto BolliJournal of Cardiovascular Pharmacology and Therapeutics|August 9, 2011
Commentary on selected aspects of cardioprotectionRobert B JenningsJournal of Cardiovascular Pharmacology and Therapeutics|August 9, 2011
Clinical efforts to reduce myocardial infarct size--the next stepEugene BraunwaldJournal of Cardiovascular Pharmacology and Therapeutics|September 2, 2011
Distinct pharmacologic substrate in lidocaine-sensitive, repetitive atrial tachycardiaPablo A Chiale, Luciano Faivelis, Hugo A Garro, et al.Journal of Cardiovascular Pharmacology and Therapeutics|March 6, 2012
Dabigatran: comparison to warfarin, pathway to approval, and practical guidelines for useVivek Iyer, Harsimran S Singh, James A ReiffelJournal of Cardiovascular Pharmacology and Therapeutics|January 21, 2012
Pioglitazone attenuates cardiac fibrosis and hypertrophy in a rat model of diabetic nephropathyRania A Elrashidy, Mervat E Asker, Hoda E MohamedPageof 129